Apomorphine Hydrochloride Injection Market

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and ?-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
Apomorphine Hydrochloride Injection Market contains market size and forecasts of Apomorphine Hydrochloride Injection in global, including the following market information:
Global Apomorphine Hydrochloride Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Apomorphine Hydrochloride Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Apomorphine Hydrochloride Injection companies in 2021 (%)
The global Apomorphine Hydrochloride Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Pen Injectors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Apomorphine Hydrochloride Injection include Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma and Evolan Pharma AB (PharmSwed), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Apomorphine Hydrochloride Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Apomorphine Hydrochloride Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Apomorphine Hydrochloride Injection Market Segment Percentages, by Type, 2021 (%)
Pen Injectors
Infusion Pumps
Global Apomorphine Hydrochloride Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Apomorphine Hydrochloride Injection Market Segment Percentages, by Application, 2021 (%)
Parkinson Disease
Erectile Dysfunction
Global Apomorphine Hydrochloride Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Apomorphine Hydrochloride Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Apomorphine Hydrochloride Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Apomorphine Hydrochloride Injection revenues share in global market, 2021 (%)
Key companies Apomorphine Hydrochloride Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Apomorphine Hydrochloride Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)